HOTH Q2 2020 Earnings — Hoth Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOTHHoth Therapeutics, Inc.

$15M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$3M

Net Income

-$2M

EPS (Diluted)

$-5.07

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

-$15,935

Balance Sheet

Total Assets

$7M

Total Liabilities

$590,093

Stockholders' Equity

$7M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$8,234	+100.0%
Operating Income	-$3M	-$1M	-98.5%
Net Income	-$2M	-$1M	-97.0%